Technical Analysis for ETON - Eton Pharmaceutcials, Inc.

Grade Last Price % Change Price Change
grade C 6.38 -6.86% -0.47
ETON closed down 6.86 percent on Wednesday, August 12, 2020, on 2.48 times normal volume.
Earnings due: Aug 14
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical ETON trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Slingshot Bullish Bullish Swing Setup -6.86%
Spinning Top Other -6.86%
Volume Surge Other -6.86%
Calm After Storm Range Contraction -6.86%
Wide Bands Range Expansion -6.86%
Gapped Down Weakness -6.86%
Shooting Star Candlestick Bearish -18.52%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Medicine Health Pharmaceutical Pain Pharmaceuticals Policy Pain Management Science And Technology In The People's Republic Of China Ophthalmic Products Allergic Conjunctivitis Liquid Products Pharmaceutical Product

Is ETON a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.74
52 Week Low 2.5
Average Volume 314,330
200-Day Moving Average 5.66
50-Day Moving Average 5.78
20-Day Moving Average 6.24
10-Day Moving Average 6.77
Average True Range 0.63
ADX 39.15
+DI 37.42
-DI 22.07
Chandelier Exit (Long, 3 ATRs ) 6.85
Chandelier Exit (Short, 3 ATRs ) 6.69
Upper Bollinger Band 7.47
Lower Bollinger Band 5.01
Percent B (%b) 0.56
BandWidth 39.41
MACD Line 0.38
MACD Signal Line 0.33
MACD Histogram 0.0425
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.58
Resistance 3 (R3) 7.59 7.19 7.38
Resistance 2 (R2) 7.19 6.89 7.19 7.31
Resistance 1 (R1) 6.79 6.70 6.99 6.78 7.25
Pivot Point 6.39 6.39 6.50 6.39 6.39
Support 1 (S1) 5.99 6.09 6.19 5.98 5.51
Support 2 (S2) 5.59 5.90 5.59 5.45
Support 3 (S3) 5.19 5.59 5.38
Support 4 (S4) 5.18